<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl3">
 <label>Table 3</label>
 <caption>
  <p>Examples of non-adamantane-based inhibitors of drug-resistant M2. NR, not reported.</p>
 </caption>
 <alt-text id="alttext0130">Table 3</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th rowspan="2">Compound</th>
    <th rowspan="2">Name</th>
    <th rowspan="2">Structure</th>
    <th colspan="3">Activity
     <hr/>
    </th>
    <th>
     <hr/>
    </th>
    <th rowspan="2">Reference</th>
   </tr>
   <tr>
    <th>Assay</th>
    <th>IC
     <sub>50</sub>/EC
     <sub>50</sub>
    </th>
    <th>Virus Strain</th>
    <th>MDCK cell toxicity (CC
     <sub>50</sub>)
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="2">
     <bold>17</bold>
    </td>
    <td align="left" rowspan="2">Polycyclic pyrrolidine</td>
    <td align="left" rowspan="2">
     <inline-graphic xlink:href="fx17_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0135">Image 17</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">WT: 3 μM
     <break/>V27A: 0.3 μM
    </td>
    <td align="left">A/Udorn/72</td>
    <td align="left" rowspan="2">10 μM</td>
    <td align="left" rowspan="2">
     <xref rid="bib102" ref-type="bibr">Rey-Carrizo et al. (2013)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">CPE</td>
    <td align="left">WT: 0.37 μM</td>
    <td align="left">A/HK/7/87</td>
   </tr>
   <tr>
    <td align="left" rowspan="2">
     <bold>18</bold>
    </td>
    <td align="left" rowspan="2">Polycyclic amine</td>
    <td align="left" rowspan="2">
     <inline-graphic xlink:href="fx18_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0140">Image 18</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">WT: 18 μM
     <break/>L26F: 8.6 μM
     <break/>V27A: 0.7 μM
    </td>
    <td align="left">A/Udorn/72</td>
    <td align="left" rowspan="2">49 μM</td>
    <td align="left" rowspan="2">
     <xref rid="bib101" ref-type="bibr">Rey-Carrizo et al. (2014)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">PRA</td>
    <td align="left">V27T+ S31N: 1.8 μM</td>
    <td align="left">A/PR/8/34</td>
   </tr>
   <tr>
    <td align="left" rowspan="3">
     <bold>19</bold>
    </td>
    <td align="left" rowspan="6">Pinanamine derivatives</td>
    <td align="left" rowspan="3">
     <inline-graphic xlink:href="fx19_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0145">Image 19</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">WT: 95% inhibition at 100 μM
     <break/>S31N: 27% inhibition at 100 μM
    </td>
    <td align="left">A/Udorn/72</td>
    <td align="left" rowspan="3">251.5 μM</td>
    <td align="left" rowspan="3">
     <xref rid="bib30" ref-type="bibr">Dong et al. (2015)</xref>; 
     <xref rid="bib149" ref-type="bibr">Zhao et al. (2012)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="2">CPE</td>
    <td align="left">WT: 3.2 μM</td>
    <td align="left">A/HK/68</td>
   </tr>
   <tr>
    <td align="left">S31N: 95.5 μM</td>
    <td align="left">A/WSN/33</td>
   </tr>
   <tr>
    <td align="left" rowspan="3">
     <bold>20</bold>
    </td>
    <td align="left" rowspan="3">
     <inline-graphic xlink:href="fx20_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0150">Image 20</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">WT: 98% inhibition at 100 μM
     <break/>S31N: 3.5% inhibition at 100 μM
    </td>
    <td align="left">A/Udorn/72</td>
    <td align="left" rowspan="3">200.2 μM</td>
    <td align="left" rowspan="3">
     <xref rid="bib31" ref-type="bibr">Dong et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="2">CPE</td>
    <td align="left">WT: 2.5 μM</td>
    <td align="left">A/HK/68</td>
   </tr>
   <tr>
    <td align="left">S31N: 3.4 μM</td>
    <td align="left">A/WSN/33</td>
   </tr>
   <tr>
    <td align="left">
     <bold>21</bold>
    </td>
    <td align="left">Spiranamine</td>
    <td align="left">
     <inline-graphic xlink:href="fx21_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0155">Image 21</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">WT: 12.6 μM
     <break/>V27A: 85 μM
    </td>
    <td align="left">A/Udorn/72</td>
    <td align="left">NR</td>
    <td align="left">
     <xref rid="bib6" ref-type="bibr">Balannik et al. (2009)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">
     <bold>22</bold>
    </td>
    <td align="left">Silaspirane derivative</td>
    <td align="left">
     <inline-graphic xlink:href="fx22_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0160">Image 22</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">WT: 13.7 μM
     <break/>V27A:
     <break/>31.3 μM
    </td>
    <td align="left">A/Udorn/72</td>
    <td align="left">NR</td>
    <td align="left">
     <xref rid="bib140" ref-type="bibr">Wang et al. (2011b)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">
     <bold>23</bold>
    </td>
    <td align="left">Hexamethylene amiloride</td>
    <td align="left">
     <inline-graphic xlink:href="fx23_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0165">Image 23</alt-text>
     </inline-graphic>
    </td>
    <td align="left">SEVC</td>
    <td align="left">WT: 1.3 μM
     <break/>S31N: 10% inhibition at 100 μM
    </td>
    <td align="left">A/HK/1073/99</td>
    <td align="left">4.7 μM</td>
    <td align="left">
     <xref rid="bib8" ref-type="bibr">Balgi et al. (2013)</xref>; 
     <xref rid="bib58" ref-type="bibr">Jalily et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="2">
     <bold>24</bold>
    </td>
    <td align="left" rowspan="6">Acylguanidine derivatives</td>
    <td align="left" rowspan="2">
     <inline-graphic xlink:href="fx24_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0170">Image 24</alt-text>
     </inline-graphic>
    </td>
    <td align="left">SEVC</td>
    <td align="left">WT: 0.2 μM</td>
    <td align="left">A/HK/1073/99</td>
    <td align="left" rowspan="2">&gt;100 μM</td>
    <td align="left" rowspan="6">
     <xref rid="bib58" ref-type="bibr">Jalily et al. (2016)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">PRA</td>
    <td align="left">WT: 2.3 μM</td>
    <td align="left">A/PR/8/34</td>
   </tr>
   <tr>
    <td align="left" rowspan="2">
     <bold>25</bold>
    </td>
    <td align="left" rowspan="2">
     <inline-graphic xlink:href="fx25_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0175">Image 25</alt-text>
     </inline-graphic>
    </td>
    <td align="left">SEVC</td>
    <td align="left">WT: 0.6 μM
     <break/>S31N: 4.4 μM
    </td>
    <td align="left">A/HK/1073/99</td>
    <td align="left" rowspan="2">55 μM</td>
   </tr>
   <tr>
    <td align="left">PRA</td>
    <td align="left">WT: 40 μM
     <break/>S31N: 18 μM
    </td>
    <td align="left">A/PR/8/34</td>
   </tr>
   <tr>
    <td align="left" rowspan="2">
     <bold>26</bold>
    </td>
    <td align="left" rowspan="2">
     <inline-graphic xlink:href="fx26_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0180">Image 26</alt-text>
     </inline-graphic>
    </td>
    <td align="left">SEVC</td>
    <td align="left">WT: 20% inhibition at 100 μM
     <break/>S31N: 42 μM
    </td>
    <td align="left">A/HK/1073/99</td>
    <td align="left" rowspan="2">25 μM</td>
   </tr>
   <tr>
    <td align="left">PRA</td>
    <td align="left">WT: 6.9 μM
     <break/>S31N: 1.5 μM
    </td>
    <td align="left">A/PR/8/34</td>
   </tr>
   <tr>
    <td align="left" rowspan="4">
     <bold>27</bold>
    </td>
    <td align="left" rowspan="4">Divalent copper complex</td>
    <td align="left" rowspan="4">
     <inline-graphic xlink:href="fx27_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0185">Image 27</alt-text>
     </inline-graphic>
    </td>
    <td align="left">TEVC</td>
    <td align="left">S31N: 90% inhibition at 100 μM</td>
    <td align="left">A/Udorn/72</td>
    <td align="left" rowspan="4">147 μM</td>
    <td align="left" rowspan="4">
     <xref rid="bib45" ref-type="bibr">Gordon et al. (2017)</xref>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="3">PRA</td>
    <td align="left">WT: 3.7 μM</td>
    <td align="left">A/Victoria/03/75</td>
   </tr>
   <tr>
    <td align="left">S31N: 0.7 μM</td>
    <td align="left">A/CA/07/09</td>
   </tr>
   <tr>
    <td align="left">S31N: 2.1 μM</td>
    <td align="left">A/WSN/33</td>
   </tr>
   <tr>
    <td align="left" rowspan="4">
     <bold>28</bold>
    </td>
    <td align="left" rowspan="4">Salinomycin</td>
    <td align="left" rowspan="4">
     <inline-graphic xlink:href="fx28_lrg.gif" xmlns:xlink="http://www.w3.org/1999/xlink">
      <alt-text id="alttext0190">Image 28</alt-text>
     </inline-graphic>
    </td>
    <td align="left" rowspan="2">Virus-like particle conductance assay</td>
    <td align="left">WT 54% inhibition at 100 μM
     <break/>S31N: 72% inhibition at 100 μM
    </td>
    <td align="left">A/PR/8/34</td>
    <td align="left" rowspan="4">35.6 μM</td>
    <td align="left" rowspan="4">
     <xref rid="bib59" ref-type="bibr">Jang et al. (2018)</xref>
    </td>
   </tr>
   <tr>
    <td align="left">M2 from influenza B: ~60% at 100 μM</td>
    <td align="left">B/Lee/40.</td>
   </tr>
   <tr>
    <td align="left" rowspan="2">CPE</td>
    <td align="left">S31N: 0.7 μM</td>
    <td align="left">A/PR/8/34</td>
   </tr>
   <tr>
    <td align="left">S31N: 1.9 μM</td>
    <td align="left">A/CA/07/09</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
